微视野作为羟氯喹视网膜病变筛查试验:Hard-Risk-1研究
该回顾性队列研究纳入197例使用羟氯喹超过5年且同时接受微视野和多焦视网膜电图检查的患者,以多焦视网膜电图作为金标准,评估微视野筛查羟氯喹视网膜病变的灵敏度与特异度。结果显示微视野灵敏度为73%、特异度为93%、阳性预测值为53%、阴性预测值为96%,提示其灵敏度较低但特异度良好,可作为排除视网膜病变的辅助检查。
要点
- 微视野筛查羟氯喹视网膜病变灵敏度73%、特异度93%、阴性预测值96%。
- 微视野灵敏度低于多焦视网膜电图,但特异度良好。
- 微视野可作为排除视网膜病变的辅助检查,尤其适用于高危或检查结果矛盾者。
核心结论
- 微视野检测羟氯喹视网膜病变的灵敏度低于多焦视网膜电图,但特异度良好。
- 微视野可作为辅助检查帮助排除视网膜病变,尤其在高危患者或不同检查结果矛盾时。
研究设计与样本
- 回顾性队列研究,纳入197例使用羟氯喹超过5年且同时接受微视野和多焦视网膜电图检查的患者。
- 以多焦视网膜电图作为金标准,其阳性定义为R1/R2环比值增高(>2.5)或R1绝对振幅降低(<9.0)。
- 微视野阳性定义为旁中心凹区域存在3个或以上连续暗点。
主要发现
- 197例患者中22例(11%)存在羟氯喹视网膜病变。
- 视网膜病变患者平均(SD)年龄54(14)岁,96%为女性。
- 视网膜病变患者平均(SD)每日剂量5.7(1.3)mg/kg,累积剂量2041(1548)g,用药时长15(10)年。
- 微视野的灵敏度、特异度、阳性预测值和阴性预测值分别为73%、93%、53%和96%。
关键数值与推荐
- 微视野阳性标准:旁中心凹区域3个或以上连续暗点。
- 多焦视网膜电图阳性标准:R1/R2环比值>2.5或R1绝对振幅<9.0。
- 微视野灵敏度73%、特异度93%、阳性预测值53%、阴性预测值96%。
临床怎么用
- 微视野可用于排除羟氯喹视网膜病变,其阴性预测值达96%。
- 在高危患者或不同检查模式结果矛盾时,可考虑将微视野作为辅助检查。
- 因微视野灵敏度较低(73%),不应单独用于确诊羟氯喹视网膜病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the sensitivity and specificity of microperimetry as a screening test to detecting hydroxychloroquine retinopathy. METHODS: Retrospective cohort study. Patients with history of hydroxychloroquine use for more than 5 years and with concomitant microperimetry and multifocal electroretinogram testing were retrospectively reviewed. Microperimetry was considered positive if there were three or more contiguous scotoma points in the parafoveal region. Multifocal electroretinogram was used as gold standard and was considered positive if there was an increased R1/R2 ring ratio (>2.5) or reduced R1 absolute amplitude (<9.0). Sensitivity, specificity, positive predictive value, and negative predictive value of microperimetry were calculated. RESULTS: A total of 197 patients were reviewed. Hydroxychloroquine retinopathy was present in 22 (11%) patients. Their mean (SD) age was 54 (14) years, and 96% were women. Their mean (SD) daily dose was 5.7 (1.3) mg/kg, cumulative dose was 2041 (1,548) g, and duration of use was 15 (10) years. Sensitivity, specificity, positive predictive value, and negative predictive value of microperimetry were 73%, 93%, 53%, and 96%, respectively. CONCLUSION: Microperimetry has inferior sensitivity but good specificity in detecting hydroxychloroquine retinopathy (compared with multifocal electroretinogram). As such, it may be a useful ancillary test to exclude retinopathy, especially in high-risk patients or those with conflicting results on different modalities.
引用
- Iftikhar M, Kaur R, Nefalar A, et al. MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY: The Hard-Risk-1 Study. Retina. 2019. PMID: 30234854. doi:10.1097/IAE.0000000000002313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。